Maple Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q1 | – | Sell |
-16,305
| Closed | -$1.84M | – | 123 |
|
2015
Q4 | $1.84M | Sell |
16,305
-1,566
| -9% | -$177K | 0.65% | 46 |
|
2015
Q3 | $1.81M | Sell |
17,871
-4,488
| -20% | -$454K | 0.67% | 48 |
|
2015
Q2 | $2.75M | Buy |
22,359
+7,365
| +49% | +$906K | 0.94% | 44 |
|
2015
Q1 | $1.72M | Buy |
14,994
+8,034
| +115% | +$919K | 0.6% | 50 |
|
2014
Q4 | $704K | Buy |
6,960
+2,685
| +63% | +$272K | 0.25% | 72 |
|
2014
Q3 | $390K | Buy |
4,275
+600
| +16% | +$54.7K | 0.15% | 83 |
|
2014
Q2 | $315K | Sell |
3,675
-150
| -4% | -$12.9K | 0.11% | 101 |
|
2014
Q1 | $301K | Hold |
3,825
| – | – | 0.12% | 104 |
|
2013
Q4 | $290K | Hold |
3,825
| – | – | 0.12% | 109 |
|
2013
Q3 | $267K | Hold |
3,825
| – | – | 0.12% | 107 |
|
2013
Q2 | $222K | Buy |
+3,825
| New | +$222K | 0.1% | 111 |
|